TOP2A and non-small cell lung carcinoma: To confirm the relationship between TOP2A (the most significantly upregulated DEG) and patient prognosis, we analyzed TOP2A protein expression in a tissue microarray (TMA) of NSCLC samples by immunohistochemistry (IHC).